维普期刊资源整合服务平台（V6.5）

23篇 您的检索式：作者名="Pronk LC"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Peripheral neuropathyinduced by combination chemotherapy of docetaxel and cispla-tin显示文摘	Hilkens PH Pronk LC Verweij J	1997	Br J Cancer1997，75，3：	1
2	a phase and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumors 显示文摘	Vasey P Sparreboom A	2000	Br J Cancer2000，83，1：	1
3	A phase Ⅰ and pharmaco kinetic study of the combination of eapecitabine and docetaxel in patients with advanced solid tumors显示文摘	Pronk LC Vasey P Sparreboom A	2000	Br J Canc er2000，83，1：	1
4	a phase and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumors显示文摘	Vasey P Sparreboom A	2000	Br J Cancer2000，83，1：	1
5	A phase I and Pharma- cokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours显示文摘	Pronk LC Vasey P Sparreboom A	2000	Br J Cancer2000，83，1：	1
6	Doeetaxel : single agent activity, development of combination treatment and reducing side-effects 显示文摘	Pronk LC Stoter G Verweij J	1995	Cancer Treat Rev1995，21，5：	1
7	A phase Ⅰ and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours显示文摘	Pronk LC Vasey P Sparreboom A	2000	Br J Cancer2000，83，1：	1
8	A phase and pharma cokinetic study of the combination of capecitabine and docetaxel in patientswith advanced solid tumors 显示文摘	Pronk LC Vasey P Sparrboom A	2000	Br J Cancer2000，83，1：	1
9	Docetaxel: single agentactivity, development of combination treatment and reducing side-effects显示文摘	Pronk LC Stoter G Verweij J	1995	Cancer Treat Rev1995，21，5：	1
10	A phase I and Pharma- cokinetic study of the combination of capecitabine and docetaxel in patientswith advanced solid tumours 显示文摘	Pronk LC Vasey P Sparreboom A	2000	Br J Cancer2000，83，1：	1
11	A phase Ⅰ and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumors 显示文摘	Pronk LC Vasey P Sparreboom A	2000	Br J Cancer2000，83，1：	1
12	Docetaxel: single agent activity, development of combination treatment and reducing side-effects显示文摘	Pronk LC Stoter G Verweij J	1995	Cancer Treatment Review1995，21，5：	1
13	Aphaseand pharmacokinetic study of the combination of capecitabine and docetaxel inpatients with advanced solid tumors显示文摘	Pronk LC Vasey P Sparrboom A	2000	Br J Cancer2000，83，1：	1
14	A phase I and Pharmacokinetic study of the combination of capccitabine and docetaxcl in patients with advanced solid tumours显示文摘	Pronk LC Vasey P Sparreboom A	2000	Br J Cancer2000，83，1：	1
15	Doeetaxel:single agent activity,development of combination treatment and reducing side-effecs显示文摘	Pronk LC Stoter G Verweij J	1995	Cancer Teat Rev1995，21，5：	1
16	Aphaseand pharmacokinetic study of the combination of capecitabine and docetaxel inpatients with advanced solid tumors显示文摘	Pronk LC Vasey P Sparrboom A	2000	Br J Cancer2000，83，1：	1
17	Docetaxel(Taxotere) :single agent activity, development of combination trcament and reducing side-effects显示文摘	Pronk LC Stote G Verwei	1995	Cancer Treat Rev1995，21，：	1
18	A phase and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumors显示文摘	Pronk LC Vasey P Sparrboom A	2000	Br J Cancer2000，83，1：	1
19	Docetaxel:single agent activity,development of combination treatment and reducing side-effects显示文摘	Pronk LC Stoter G Verweij J	1995	Cancer Treatment Review1995，21，5：	1
20	Phase I and pharmacologic study of docetaxel and cisplatin in patients with advanced solid tumors显示文摘	Pronk LC Schellens JH Planting AS	1997	J Clin Oncol1997，15，3：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示